0001179110-14-000628.txt : 20140107 0001179110-14-000628.hdr.sgml : 20140107 20140107165403 ACCESSION NUMBER: 0001179110-14-000628 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140103 FILED AS OF DATE: 20140107 DATE AS OF CHANGE: 20140107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Christopher G CENTRAL INDEX KEY: 0001537668 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 14514055 MAIL ADDRESS: STREET 1: C/O AMAG PHARMACEUTICALS, INC. STREET 2: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 edgar.xml FORM 4 - X0306 4 2014-01-03 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001537668 White Christopher G 1100 WINTER STREET WALTHAM MA 02451 0 1 0 0 Chief Business Officer Common Stock 2014-01-06 4 S 0 2500 23.69 D 31334 D Common Stock 2014-01-07 4 S 0 2500 24.10 D 28834 D The shares reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.30 - $23.95. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price. This total includes 5,000 shares delivered to the reporting person on January 3, 2014 pursuant to the partial vesting of a restricted stock unit award granted to the reporting person on January 3, 2012 and of which 2,500 shares were sold on January 6, 2014 as reported in this Form 4. This total also includes 834 unvested restricted stock units granted on February 24, 2010, 8,000 unvested restricted stock units granted pursuant to two separate grants on January 7, 2011, and 5,000 unvested restricted stock units granted on January 3, 2012, all of which were previously reported on Table II. Thus, after taking into account the delivery of shares on January 3, 2014, this total includes an aggregate of 18,834 unvested restricted stock units previously reported on Table II. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.84 - $24.82. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price. Nancy R. Smith, attorney-in-fact 2014-01-07